Literature DB >> 27324791

Glucose Metabolism and AMPK Signaling Regulate Dopaminergic Cell Death Induced by Gene (α-Synuclein)-Environment (Paraquat) Interactions.

Annadurai Anandhan1,2, Shulei Lei3, Roman Levytskyy4, Aglaia Pappa5, Mihalis I Panayiotidis6, Ronald L Cerny3, Oleh Khalimonchuk4, Robert Powers7, Rodrigo Franco8,9.   

Abstract

While environmental exposures are not the single cause of Parkinson's disease (PD), their interaction with genetic alterations is thought to contribute to neuronal dopaminergic degeneration. However, the mechanisms involved in dopaminergic cell death induced by gene-environment interactions remain unclear. In this work, we have revealed for the first time the role of central carbon metabolism and metabolic dysfunction in dopaminergic cell death induced by the paraquat (PQ)-α-synuclein interaction. The toxicity of PQ in dopaminergic N27 cells was significantly reduced by glucose deprivation, inhibition of hexokinase with 2-deoxy-D-glucose (2-DG), or equimolar substitution of glucose with galactose, which evidenced the contribution of glucose metabolism to PQ-induced cell death. PQ also stimulated an increase in glucose uptake, and in the levels of glucose transporter type 4 (GLUT4) and Na+-glucose transporters isoform 1 (SGLT1) proteins, but only inhibition of GLUT-like transport with STF-31 or ascorbic acid reduced PQ-induced cell death. Importantly, while autophagy protein 5 (ATG5)/unc-51 like autophagy activating kinase 1 (ULK1)-dependent autophagy protected against PQ toxicity, the inhibitory effect of glucose deprivation on cell death progression was largely independent of autophagy or mammalian target of rapamycin (mTOR) signaling. PQ selectively induced metabolomic alterations and adenosine monophosphate-activated protein kinase (AMPK) activation in the midbrain and striatum of mice chronically treated with PQ. Inhibition of AMPK signaling led to metabolic dysfunction and an enhanced sensitivity of dopaminergic cells to PQ. In addition, activation of AMPK by PQ was prevented by inhibition of the inducible nitric oxide syntase (iNOS) with 1400W, but PQ had no effect on iNOS levels. Overexpression of wild type or A53T mutant α-synuclein stimulated glucose accumulation and PQ toxicity, and this toxic synergism was reduced by inhibition of glucose metabolism/transport and the pentose phosphate pathway (6-aminonicotinamide). These results demonstrate that glucose metabolism and AMPK regulate dopaminergic cell death induced by gene (α-synuclein)-environment (PQ) interactions.

Entities:  

Keywords:  Adenosine monophosphate-activated kinase; Autophagy; Glucose transporters; Glycolysis; Metabolomics; Parkinson’s disease; Pesticides; α-Synuclein

Mesh:

Substances:

Year:  2016        PMID: 27324791      PMCID: PMC5173445          DOI: 10.1007/s12035-016-9906-2

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  96 in total

1.  Production and titration of lentiviral vectors.

Authors:  Isabelle Barde; Patrick Salmon; Didier Trono
Journal:  Curr Protoc Neurosci       Date:  2010-10

Review 2.  Genetics of Parkinson's disease.

Authors:  Christine Klein; Ana Westenberger
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

3.  Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells.

Authors:  L J Reitzer; B M Wice; D Kennell
Journal:  J Biol Chem       Date:  1979-04-25       Impact factor: 5.157

4.  Superoxide mediates the actions of angiotensin II in the central nervous system.

Authors:  Matthew C Zimmerman; Eric Lazartigues; Julie A Lang; Puspha Sinnayah; Iman M Ahmad; Douglas R Spitz; Robin L Davisson
Journal:  Circ Res       Date:  2002-11-29       Impact factor: 17.367

5.  The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein.

Authors:  Amy B Manning-Bog; Alison L McCormack; Jie Li; Vladimir N Uversky; Anthony L Fink; Donato A Di Monte
Journal:  J Biol Chem       Date:  2001-11-13       Impact factor: 5.157

Review 6.  Mitochondrial biology and Parkinson's disease.

Authors:  Celine Perier; Miquel Vila
Journal:  Cold Spring Harb Perspect Med       Date:  2012-02       Impact factor: 6.915

7.  Myc-induced AMPK-phospho p53 pathway activates Bak to sensitize mitochondrial apoptosis.

Authors:  Anni I Nieminen; Vilja M Eskelinen; Heidi M Haikala; Topi A Tervonen; Yan Yan; Johanna I Partanen; Juha Klefström
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-15       Impact factor: 11.205

8.  Utilities for quantifying separation in PCA/PLS-DA scores plots.

Authors:  Bradley Worley; Steven Halouska; Robert Powers
Journal:  Anal Biochem       Date:  2012-10-15       Impact factor: 3.365

9.  The protective role of AMP-activated protein kinase in alpha-synuclein neurotoxicity in vitro.

Authors:  Marija Dulovic; Maja Jovanovic; Maria Xilouri; Leonidas Stefanis; Ljubica Harhaji-Trajkovic; Tamara Kravic-Stevovic; Verica Paunovic; Mustafa T Ardah; Omar M A El-Agnaf; Vladimir Kostic; Ivanka Markovic; Vladimir Trajkovic
Journal:  Neurobiol Dis       Date:  2013-11-20       Impact factor: 5.996

10.  Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain.

Authors:  Latha Devi; Vijayendran Raghavendran; Badanavalu M Prabhu; Narayan G Avadhani; Hindupur K Anandatheerthavarada
Journal:  J Biol Chem       Date:  2008-02-01       Impact factor: 5.157

View more
  18 in total

Review 1.  Metabolic Dysfunction in Parkinson's Disease: Bioenergetics, Redox Homeostasis and Central Carbon Metabolism.

Authors:  Annadurai Anandhan; Maria S Jacome; Shulei Lei; Pablo Hernandez-Franco; Aglaia Pappa; Mihalis I Panayiotidis; Robert Powers; Rodrigo Franco
Journal:  Brain Res Bull       Date:  2017-03-21       Impact factor: 4.077

2.  Metabolomics Analyses from Tissues in Parkinson's Disease.

Authors:  Fatema Bhinderwala; Shulei Lei; Jade Woods; Jordan Rose; Darrell D Marshall; Eli Riekeberg; Aline De Lima Leite; Martha Morton; Eric D Dodds; Rodrigo Franco; Robert Powers
Journal:  Methods Mol Biol       Date:  2019

3.  mTOR/AMPK signaling in the brain: Cell metabolism, proteostasis and survival.

Authors:  Carla Garza-Lombó; Annika Schroder; Elsa M Reyes-Reyes; Rodrigo Franco
Journal:  Curr Opin Toxicol       Date:  2018-05-17

Review 4.  Beyond the paradigm: Combining mass spectrometry and nuclear magnetic resonance for metabolomics.

Authors:  Darrell D Marshall; Robert Powers
Journal:  Prog Nucl Magn Reson Spectrosc       Date:  2017-01-11       Impact factor: 9.795

5.  Chicken heterophils extracellular traps act as early effectors against cyclopiazonic acid dependent upon NADPH oxidase, ROS and glycolysis.

Authors:  Liqiang Jiang; Shuangqiu Li; Di Wu; Aimin Jiang; Ziyi Liu; Xingyi Zhu; Yong Zhang; Jingnan Xu; Xinxin Gao; Wei Liu; Zhengtao Yang; Zhengkai Wei
Journal:  Arch Toxicol       Date:  2022-05-04       Impact factor: 6.168

Review 6.  Metabolic Investigations of the Molecular Mechanisms Associated with Parkinson's Disease.

Authors:  Robert Powers; Shulei Lei; Annadurai Anandhan; Darrell D Marshall; Bradley Worley; Ronald L Cerny; Eric D Dodds; Yuting Huang; Mihalis I Panayiotidis; Aglaia Pappa; Rodrigo Franco
Journal:  Metabolites       Date:  2017-05-24

Review 7.  Recent advances and perspectives of metabolomics-based investigations in Parkinson's disease.

Authors:  Yaping Shao; Weidong Le
Journal:  Mol Neurodegener       Date:  2019-01-11       Impact factor: 14.195

8.  The pentose phosphate pathway regulates chronic neuroinflammation and dopaminergic neurodegeneration.

Authors:  Dezhen Tu; Yun Gao; Ru Yang; Tian Guan; Jau-Shyong Hong; Hui-Ming Gao
Journal:  J Neuroinflammation       Date:  2019-12-05       Impact factor: 8.322

9.  BNIP3L-Dependent Mitophagy Promotes HBx-Induced Cancer Stemness of Hepatocellular Carcinoma Cells via Glycolysis Metabolism Reprogramming.

Authors:  Yuan-Yuan Chen; Wei-Hua Wang; Lin Che; You Lan; Li-Yin Zhang; Deng-Lin Zhan; Zi-Yan Huang; Zhong-Ning Lin; Yu-Chun Lin
Journal:  Cancers (Basel)       Date:  2020-03-11       Impact factor: 6.639

Review 10.  Targeting AMPK Signaling as a Neuroprotective Strategy in Parkinson's Disease.

Authors:  Daniel W Curry; Bernardo Stutz; Zane B Andrews; John D Elsworth
Journal:  J Parkinsons Dis       Date:  2018       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.